Tornier BV (TRNX) Rated at “Outperform” by William Blair

Equities research analysts at William Blair Rated shares of Tornier BV (NASDAQ:
TRNX) a Outperform rating in a research note released to investors today.
Tornier N.V. operates as a medical device company offering products that treat
orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The
Companys products are organized in four major categories: upper extremity joints
and trauma, lower extremity joints and trauma, sports medicine and
orthobiologics, and large joints and other. The upper extremity products include
joint replacement and bone fixation devices for the shoulder, hand, wrist and
elbow; lower extremity products include joint replacement and bone fixation
devices for the foot and ankle; sports medicine and orthobiologics product
category includes products used across several anatomic sites to mechanically
repair tissue-to-tissue or tissue-to-bone injuries; and large joints and other
products include hip and knee joint replacement implants and ancillary products.
Tornier N.V. is based in Amsterdam, The Netherlands. Shares of Tornier BV
(NASDAQ: TRNX) are trading down -2.12% as of Mar 16, 12:54PM EDT, hitting 18.60.
Tornier BV has a 52 week low of 17.80 and a 52 week high of 19.17. The companies
last released earnings were -1.43 per share. were The company has a market cap
of 706.58M and a price-to-earnings ratio of . FavStocks.com - Tornier BV (TRNX)
Rated at Outperform by William Blair Contributed by FavStocks Staff Please visit
FavStocks.com for more info on your Favorite Stocks . Also stop by the free
Stock Forum and discuss todays hot stocks. )